Premature coronary artery disease: Role of free radical nitric oxide

Indian Heart Journal

Volumn 60, Issue 1, 2008, Pages 45-49

  Ravi Kanth, V V ^a   Prakash, G J ^a   Naik, Sudhir ^b   Kabra, Nitin ^c   Sujatha, M ^a,d  

^a OSMANIA UNIVERSITY   (India)

^b Mediciti Hospital   (India)

^c Gandhi Hospital   (India)

^d Institute and Hospital

Author keywords

Free radical; Nitric oxide; Oxidative stress; Pre CAD; ROS

Indexed keywords

FREE RADICAL; NITRIC OXIDE;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEART INFARCTION; HUMAN; LIFESTYLE; OCCUPATION; OXIDATIVE STRESS; SITTING;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; RISK FACTORS;

EID: 48749128375     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Schnackenberg CG. Oxygen radicals in cardiovascular-renal disease. Curr Opin Pharmocol 2002;2:121-125.
2. Maytin M, Leopoid J, Loscalzo J. Oxidant stress in the vasculature. Curr Atheroscler Rep 1999;1:156-164.
3. Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low-density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001;103:1955-1960.
4. Tsutsui T, Tsutamoto T, Wada A, et al. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. J Am Coll Cardiol 2002;39:957-962.
5. Galle J, Heermeier K. Angiotensin II and oxidized LDL: an unholy alliance creating oxidative stress. Nephrol Dial Transplant 1999;14:2585-2589.
6. Patterson C, Madamanchi NR, Runge MS. The oxidative paradox: another piece in the puzzle. Cir Res 2000;87:1074-1076.
7. Li D, Williams V, Liu L, et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 2003;41:1048-1055.
8. Warnholtz A, Nickenig G, Schulz E, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999;99:2027-2033.
9. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996;20:707-727.
10. Mahesh SJ, Julie LP, Jack RLJR. Cellular anti-oxidant and pro-oxidant actions of nitric oxide. Free Rad Biol Med 1999;27:1357-1366.
11. Koh E, Noh SH, Lee YD, et al. Differential expression of nitric oxide synthase in human stomach cancer. Cancer Lett 1999;146:173-180.
12. Vakkala M, Kahlos K, Lakari E, Paakko P, Kinnula V, Soini Y. Indicible nitric oxide sunthase expression, apoptosis and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res 2000;6:2408-2416.
13. Oshima H, Bartsch H. Chronic infections and inflammatory process as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305: 253-264.
14. Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection inflammation, and cancer. Biochemistry 1998;63:854-65.
15. Alagol H, Erdem E, Sancak B, Turkmen G, Camlibel M, Bugdayci G. Nitric oxide biosynthesis and malondialdehyde levels in advanced breast cancer. Aust N Z J Surg 1999;69:647-50.
16. Moshage H, Kok B, Huizenga JR, Jansen PL Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995;41:892-6.
17. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 1995;41:904-7.
18. Carla B, Patrizia F, Sergio AT, Carla V, Francesco R, Antonio F. Vitamin E serum levels and gastric cancer: results from a cohort of patients in Tuscany, Italy. Cancer Lett 2000;151:15-8.
19. Jenkins DC, Chrles IG, Thomsen LL, et al. Role of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995;92:4392-4396.
20. Zalba G, Beaumont J, San Jose G, Fortuno MA, Diez J. Vascular oxidant stress: molecular mechanisms and pathophysiological implications. J Physiol Biochem 2000;56:57-64.
21. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidative stress. Cir Res 2000;87:840-844.
22. Panza JA, Quyyumi AA, Brush JE Jr, Epstein Se. Abnormal endothelial dependent vascular relaxation in patients with ssential hypertension. N Engl J Med 1990;323:22-27.
23. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456.
24. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915-7922.
25. Yu BP, Yang R. Critical evaluation of free radical theory of aging: A proposal for the oxidative stress hypothesis. Ann N Y Acad Sci 1996;786:1-11.
26. Sohal RS, Orr WC. Is oxidative stress a causal factor in aging? In: Esser K, Martin GM, eds. Molecular Aspects of Aging Chichester: John Wiley & Sons, 1995:109-127.
27. Halliwell B. Oxidative stress, nutrition and health: experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996;25:57-74.
28. Ames BN, Shigenaga MK. Oxidants are a major contributor to aging. Ann N Y Acad Sci 1992;663:85-96.
29. Yu BP (ed). Free Radicals in Aging Boca Raton, FL: CRC Press, 1993.
30. Yu BP. Aging and oxidative stress: modulation by dietary restriction. Free Radic Biol Med 1991;21:651-668.